News
09-18-2015, 06:10 AM
University of Manchester researchers funded by Breast Cancer Now have discovered a new explanation as to why women with oestrogen receptor positive (ER+) breast cancer develop resistance to hormone treatment, and a potential new approach to overcome the problem.
More... (http://www.news-medical.net/news/20150918/Manchester-researchers-reveal-why-ER2b-breast-cancer-women-develop-resistance-to-hormone-therapy.aspx)
More... (http://www.news-medical.net/news/20150918/Manchester-researchers-reveal-why-ER2b-breast-cancer-women-develop-resistance-to-hormone-therapy.aspx)